New to Meducation?
Sign up
Already signed up? Log In

Category

1
1
18

VPB2 2009 | Case 9

ResearchToPractice.com/VPB209 - Case 9: A 62-year-old woman with bilateral (10 centimeters and 15 centimeters), Grade III, node-positive, ER-positive, HER2-negative IDCs with focal lobular features and bone metastases. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
2
1
23

VPB2 2009 | Case 10

ResearchToPractice.com/VPB209 - Case 10: A 47-year-old premenopausal woman with a family history of breast and ovarian cancer who refuses hormonal therapy for a 1.9-cm, Grade III, node-positive, ER-positive, PR-positive, HER2-positive IDC. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
3
1
15

VPB2 2009 | Case 11

ResearchToPractice.com/VPB209 - Case 11: A 47-year-old woman with extensive, high-grade, multifocal ductal carcinoma in situ (DCIS), a 3-mm focus of ER-positive, PR-negative, HER2-positive IDC and an Oncotype DX Recurrence Score of 34 (high risk). Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
4
1
14

VPC1 2009 | Case 1

ResearchToPractice.com/VPC109 - Case 1: A 61-year-old woman with an obstructing, K-ras wild-type colon cancer and three synchronous liver metastases who underwent subtotal colectomy followed by CAPOX and partial hepatectomy. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
5
1
14

VPC1 2009 | Case 2

ResearchToPractice.com/VPC109 - Case 2: A 77-year-old woman with a 9-cm, K-ras wild-type colon cancer and 42 out of 47 positive nodes who underwent resection of her primary tumor followed by adjuvant FOLFOX and subsequently developed a retroperitoneal metastasis treated with CAPOX/bevacizumab. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
6
1
12

VPC1 2009 | Case 3

ResearchToPractice.com/VPC109 - Case 3: A 57-year-old woman with T3N1 sigmoid colon cancer who received adjuvant FOLFOX. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
7
1
15

VPC1 2009 | Case 4

ResearchToPractice.com/VPC109 - Case 4: A 61-year-old woman with a 1.5-cm, K-ras mutation-positive, biopsy-proven metastasis to the lung 3.5 years after resection and chemoradiation therapy for rectal cancer. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
8
1
10

VPC1 2009 | Case 5

ResearchToPractice.com/VPC109 - Case 5: A 47-year-old woman with extrahepatic and hepatic metastases and lung nodules seven years after treatment for T3N0, K-ras wild-type colon cancer. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
9
1
15

VPC1 2009 | Case 6

<p>ResearchToPractice.com/VPC109 - Case 6: A 63-year-old woman with T3N2M1, K-ras wild-type colon cancer underwent right colectomy and received CAPOX/bevacizumab for 10 months before discontinuin <br />therapy and one year later underwent a pancreaticoduodenectomy for a tumor involving the duodenum, jejunum and pancreas. Interviews conducted by Neil Love, MD. Produced by Research To Practice.</p>  
Dr Neil Love
over 8 years ago
12
1
16

VPC1 2009 | Case 9

ResearchToPractice.com/VPC109 - Case 9: A 57-year-old woman with poorly differentiated T3N0 adenocarcinoma of the sigmoid colon with minimal lymphovascular invasion received adjuvant FOLFOX. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
13
1
18

VPC1 2009 | Case 10

ResearchToPractice.com/VPC109 - Case 10: A 45-year-old woman with nearly obstructing, K-ras wild-type sigmoid colon cancer and diffuse, bilobar hepatic metastases who underwent one-step radiofrequency ablation of liver metastases and removal of the sigmoid colon. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
3
1
15

VPL1 2009 | Case 1

ResearchToPractice.com/VPL109 – Case 1: A 45-year-old woman with a poorly differentiated papillary carcinoma of the lung with brain and adrenal metastases. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
5
1
12

VPL1 2009 | Case 3

ResearchToPractice.com/VPL109 – Case 3: A 47-year-old woman with adenocarcinoma metastatic to the bone and axillary lymph nodes with a complete response to carboplatin/docetaxel/bevacizumab with zoledronic acid. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
7
1
12

VPL1 2009 | Case 5

ResearchToPractice.com/VPL109 – Case 5: A 66-year-old woman with a Stage IIIB adenocarcinoma of the lung treated with carboplatin/docetaxel/bevacizumab followed by maintenance pemetrexed/bevacizumab. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
9
1
16

VPL1 2009 | Case 7

ResearchToPractice.com/VPL109 – Case 7: A 62-year-old woman who received adjuvant cisplatin/docetaxel after resection of a Stage IIIA adenocarcinoma of the lung. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
10
1
10

VPL1 2009 | Case 8

ResearchToPractice.com/VPL109 – Case 8: A 55-year-old woman, a nonsmoker, who received single-agent erlotinib for bronchoalveolar carcinoma. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
12
1
17

VPL1 2009 | Case 10

ResearchToPractice.com/VPL109 – Case 10: A 53-year-old woman, a nonsmoker, who received erlotinib/bevacizumab for metastatic adenocarcinoma of the lung. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
13
1
11

VPL1 2009 | Case 11

ResearchToPractice.com/VPL109 – Case 11: A 51-year-old woman with advanced adenocarcinoma of the lung treated with temozolomide and external-beam radiation therapy for brain metastases followed by carboplatin/docetaxel with bevacizumab. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
0
1
14

VPL1 2009 | Case 12

ResearchToPractice.com/VPL109 – Case 12: An 83-year-old woman, a nonsmoker, with metastatic adenocarcinoma of the lung and a sustained complete remission to erlotinib/bevacizumab. Interviews conducted by Neil Love, MD. Produced by Research To Practice.  
Dr Neil Love
over 8 years ago
29634
1
35

Step 3 - Ten Steps to Successful Breastfeeding

Every facility providing maternity services and care for newborn infants should: Inform all pregnant women about the benefits and management of breastfeeding. If the hospital has an affiliated antenatal clinic or antenatal ward...breastfeeding counseling [should be] given to most pregnant women using those services...The antenatal discussion should cover the importance of exclusive breastfeeding for the first 4-6 months, the benefits of breastfeeding, and basic breastfeeding management...Pregnant women of 32 weeks or more gestation...should confirm that the benefits of breastfeeding have been discussed with them...[including] at least two of the following benefits: Nutritional, protective, bonding, health benefits to the mother...and that they have received no group education on the use of infant formula. They should be able to describe at least two of the following breastfeeding management topics: importance of rooming-in, importance of feeding on demand, how to assure enough milk, and positioning and attachment. The third step is to have sessions with pregnant women to motivate them for breastfeeding and to remove all their doubts. More inf http://tensteps.org/step-3-successful-breastfeeding.shtml Benefits of Breastfeedin http://tensteps.org/benefits-of-breastfeeding.shtml Benefits for Infan http://tensteps.org/benefits-of-breastfeeding-for-the-infant.shtml Benefits for Mothe http://tensteps.org/benefits-of-breastfeeding-for-the-mother.shtml Benefits for the Famil http://tensteps.org/benefits-of-breastfeeding-for-the-family.shtml Benefits for the Hospita http://tensteps.org/benefits-of-breastfeeding-for-the-hospital.shtml Benefits for the Environment & Societ http://tensteps.org/benefits-of-breastfeeding-for-the-environment-society.shtml Other Benefit http://tensteps.org/benefits-of-breastfeeding-other.shtml --.-- Ten Steps to Successful Breastfeeding - Video Series Babies who are breastfed are generally healthier and achieve optimal growth and development compared to those who are fed formula milk. If the vast majority of babies were exclusively fed breastmilk in their first six months of life -- meaning only breastmilk and no other liquids or solids, not even water -- it is estimated that the lives of at least 1.2 million children would be saved every year. If children continue to be breastfed up to two years and beyond, the health and development of millions of children would be greatly improved. This video series aims to raise awareness, encourage early adoption, promote training of health care staff, and build capacity for, and to stimulate dialogue about, breastfeeding and its impact on the public, in a range of community and public contexts in low- and middle-income countries. Our goal is to have these ten steps in every facility providing maternal services and care for newborn infants. Videos, presentations, research, evidence, papers, training and counselling materials, tools, and many other related and supporting resources are available. Visit us on-line a http://tensteps.org .  
Nand Wadhwani
over 8 years ago